N. Ogawa

Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.

S. Inoue, Yusuke Suzuki, T. Yokomizo, 2019, Biochemical and biophysical research communications.

cDNA cloning of a novel trypsin inhibitor with similarity to pathogenesis-related proteins, and its frequent expression in human brain cancer cells.

N. Koshikawa, H. Yasumitsu, K. Miyazaki, 1998, Biochimica et biophysica acta.

Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.

F. Uchiumi, S. Inoue, T. Yokomizo, 2020, Biochemical and biophysical research communications.

Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.

H. Hashimoto, A. Baba, T. Matsuda, 1997, Molecular pharmacology.

Identification of the initiation region of DNA replication in the murine immunoglobulin heavy chain gene and possible function of the octamer motif as a putative DNA replication origin in mammalian cells.

S. Iguchi-Ariga, H. Ariga, S M Iguchi-Ariga, 1993, Biochimica et biophysica acta.

Structure of the gene encoding the mouse pituitary adenylate cyclase-activating polypeptide receptor.

H. Hashimoto, A. Baba, S. Nagata, 1995, Gene.

cDNA cloning of a mouse pituitary adenylate cyclase-activating polypeptide receptor.

H. Hashimoto, A. Baba, T. Matsuda, 1996, Biochimica et biophysica acta.

Identification and characterization of parathyroid hormone/parathyroid hormone-related peptide receptor in cultured astrocytes.

H. Hashimoto, A. Baba, S. Nagata, 1994, Biochemical and biophysical research communications.

Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages.

F. Uchiumi, T. Yokomizo, S. Tanuma, 2021, Archives of biochemistry and biophysics.